Page last updated: 2024-11-04

rolipram and Amnionitis

rolipram has been researched along with Amnionitis in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Chorioamnionitis is implicated in the pathophysiology of bronchopulmonary disease, and the associated inflammatory response is responsible for adverse effects on alveolar development."1.38Antenatal phosphodiesterase 4 inhibition restores postnatal growth and pulmonary development in a model of chorioamnionitis in rabbits. ( Branger, B; Caillon, J; Gras-Leguen, C; Homer, L; Jacqueline, C; Jarreau, PH; Joram, N; Launay, E; Méhats, C; Moyon, T; Potel, G; Roze, JC, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Homer, L1
Launay, E1
Joram, N1
Jacqueline, C1
Jarreau, PH1
Caillon, J1
Moyon, T1
Branger, B1
Potel, G1
Roze, JC1
Méhats, C1
Gras-Leguen, C1

Other Studies

1 other study available for rolipram and Amnionitis

ArticleYear
Antenatal phosphodiesterase 4 inhibition restores postnatal growth and pulmonary development in a model of chorioamnionitis in rabbits.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 340, Issue:3

    Topics: Animals; Chorioamnionitis; Disease Models, Animal; Elastic Tissue; Female; Lung; Lung Volume Measure

2012